Bone Marrow TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationHepatic Veno-Occlusive DiseaseGraft vs Host DiseaseTransplantation ConditioningWhole-Body IrradiationAnemia, AplasticLeukemiaTransplantation, AutologousBone MarrowBone Marrow CellsHematologic NeoplasmsT-LymphocytesHematopoietic Stem CellsTransplantation ChimeraMice, Inbred C57BLTissue DonorsLiver TransplantationStem Cell TransplantationHistocompatibility TestingMyeloablative AgonistsGraft SurvivalLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHistocompatibilityBusulfanTreatment OutcomeUnrelated DonorsKidney TransplantationPeripheral Blood Stem Cell TransplantationRecurrenceRetrospective StudiesBone and BonesLeukemia, Myeloid, AcuteImmunosuppressive AgentsTime FactorsRemission InductionCord Blood Stem Cell TransplantationImmunosuppressionGraft RejectionHematopoiesisGraft vs Tumor EffectCyclophosphamideHLA AntigensSurvival AnalysisCombined Modality TherapyTransplantation ImmunologyTransplantation, IsogeneicGraft vs Leukemia EffectMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow PurgingHeart TransplantationChimerismVidarabineSurvival RateHematologic DiseasesCell TransplantationAcute DiseaseDisease-Free SurvivalLymphoma, Non-HodgkinLung TransplantationSiblingsCyclosporineLymphocyte DepletionLymphocyte TransfusionFollow-Up StudiesSevere Combined ImmunodeficiencyBone Marrow DiseasesTransplantationLeukemia, MyeloidMultiple MyelomaRadiation ChimeraOrgan TransplantationCytomegalovirus InfectionsDonor SelectionAntilymphocyte SerumAntineoplastic Combined Chemotherapy ProtocolsPostoperative ComplicationsLiving DonorsAntigens, CD34Colony-Forming Units AssayCell DifferentiationBone Marrow ExaminationIslets of Langerhans TransplantationGraft vs Host ReactionLeukocyte TransfusionMinor Histocompatibility AntigensMelphalanFlow CytometryChimeraLymphomaPrognosisHodgkin DiseasePancreas TransplantationRisk FactorsHematopoietic Stem Cell MobilizationBone Marrow NeoplasmsInfectionBone Remodeling